Posts Tagged ‘economic analysis’
April 16, 2024 — Right now GLP-1 medicines for obesity carry high list prices that engender great debates about how many billions (hyperbolists will say trillions) of dollars treating obesity will cost healthcare systems. For the uninitiated, it’s quite natural to think of metabolic procedures and obesity medicine in terms of either/or questions. No matter that this is a […]
March 20, 2024 — There is a hot debate playing out in medical journals and editorials all over the country. How can we pay for the advanced obesity medicines for which people are expressing such a great need? What often gets lost in this discussion is the fact that we are already paying. Yesterday, we had the good fortune […]
July 4, 2023 — JAMA Pediatrics has a pair of new papers today on the cost of childhood obesity. One of them adds up the medical expenses incurred by youth aged 2 to 19. The other editorializes about determining the value of interventions to manage weight. Both of them focus on pricing childhood obesity in the present while discounting […]
June 29, 2023 — After four exhilarating days of new possibilities for overcoming diabetes and obesity at ADA2023, we had to come back down to earth. The National Institute for Health and Clinical Excellence in the UK stepped up to this task right away. On Tuesday, NICE said nope to recommending tirzepatide use for type 2 diabetes in the […]
July 14, 2022 — We’ve all got our reading assignments. The Institute for Clinical and Economic Review (ICER) has released its draft report on effectiveness and value for the current options in obesity medicine. There’s a lot to process in there. But the bottom line is clear enough. Phentermine/topiramate (Qsymia) offers the best value, says the report. The most […]
November 13, 2021 — Jeff Colgan and Miriam Hinthorn have a provocative new paper suggesting that cheap gas drives obesity prevalence higher. At first glance, the title of their paper borders on sensational: “Is cheap gasoline killing us?” It worked. They made us look, even though (or perhaps because) the implicit claim of cause and effect is so absurd. […]